RFA TOO SOON FOR MANY RED SOX FANS, BUT HERE AT FENWAY TODAY THEY WERE AEBL TO HIGHLIGHT NOT ONLY VETERANS BUT ALSO SURVIVORS OF LUNG CANCER. TAKE OUTO T ME IT’S BOTH SEASON IS OVER, BUT THAT DI’N'T ...

CINCINNATI (WKRC) - It's a yearly screening available at no cost to detect lung cancer early, but many people who qualify for it don’t even know it’s available. It’s all part of The White Ribbon ...

The UK Lung cancer screening trial (UKLS) has been successfully completed and demonstrated that patients with a high risk of developing lung cancer can be identified with early stage disease and have ...

Significant research funding in the form of a five-year, $12.1 million U19 Grant from the National Institutes of Health (NIH) has been awarded to a collaboration of research teams co-led by ...

During National Lung Cancer Screening Awareness Month, University of Kentucky researchers were traveling across the commonwealth to talk to Kentuckians about lung health. It’s a project built for ...

Goals of this project were twofold: 1) evaluate the change in primary care provider behaviors in terms of referrals for CT screening referrals following both provider education and implementation of a ...

Public Health Relevance Statement: Idiopathic Pulmonary Fibrosis (IPF) is fatal lung disorder for which no U.S. FDA-approved drugs currently exist. This project will lead to the development of novel ...

Screening may lead to overdiagnosis of lung cancer, a study reports in the June 7 issue of the Journal of the National Cancer Institute. Screening for cancer can find tumors that might not otherwise ...

Hemithoracic radiation therapy and brachytherapy after pleurectomy/decortication for malignant pleural mesothelioma: Results from a 30-year experience No significant ...

Stephen Huff was diagnosed with stage 4 lung cancer almost four years ago. Back then, in 2017, he was 29 years old. He was just embarking on his "adult life." "It was obviously a shock to get a cancer ...

CAMBRIDGE, England--(BUSINESS WIRE)--CN Bio, a leading developer of single- and multi-organ-on-chip microphysiological systems (MPS) that improve the accuracy and efficiency of drug discovery, today ...